Healthcare / Elderly CareGlobal
← Sticker Wall
JOURNEY · DETAIL
Philips: A Century-Old Giant from Carbon-Filament Lamp Invention to Medical Technology and Consumer Electronics
Founded: Gerard Philips, Frederik Philips · Koninklijke Philips N.V. (Royal Philips)
JOURNEY
Key Fields
FIELD STAMPSIndustryHealthcare / Elderly Care
RegionGlobal
ScaleGiant
ChannelOther
Origin
In 1891, mechanical engineer Gerard Philips, with financial backing from his father Frederik, founded Philips & Co in Eindhoven, engaging in the manufacturing and trade of incandescent lamps and other electrical products. According to historical accounts, his bulbs had a lifespan 20% longer than competitors while costing 50% more to produce; early Russian orders contributed about 50% of the company's revenue by 1914. In 1912, the company went public on the Amsterdam Stock Exchange, laying the capital foundation for its eventual pivot to medical technology.
Milestones
1891
Startup and Inception Growth
In 1891, Gerard Philips and his father Frederik founded the Philips company in Eindhoven, Netherlands, initially producing only carbon-filament lamps. As Thomas Edison's relevant patents expired in Europe, Philips was able to legally replicate and improve bulb manufacturing techniques, selling about 400 carbon-filament lamps in its first year. Relying on family capital and the opportunity presented by local electrification, this small workshop scaled its production to tens of thousands of units within just three years.
1912
IPO and Expansion Turning Point
In 1912, Philips went public on the Amsterdam Stock Exchange, leveraging the capital markets to raise funds for expanding lighting production capacity and beginning to set up overseas sales and manufacturing bases. Following the IPO, Philips transformed from a small family factory into Europe's third-largest lighting manufacturer, using public capital and modern corporate governance to support its international footprint—a watershed moment in Philips' evolution into a large industrial conglomerate.
1914
R&D Pivot Inflection Point
In 1914, Philips established the NatLab (Natuurkundig Laboratorium), hiring scientists such as Dutch physicist Gilles Holst to engage in fundamental electronics research. The laboratory soon developed X-ray tubes, helping Philips branch out from lighting into medical equipment. This technological leap provided Philips with the second growth curve of medical technology over the following century.
1983
Standard Zenith Growth
In 1983, Philips and Japan's Sony jointly released the Compact Disc (CD) standard, simultaneously launching CD players. Relying on its patent accumulation in optical storage and digital encoding, Philips collected substantial licensing fees from CD and later DVD standards, bringing its consumer electronics business to its peak. However, the profitability of the CD business masked Japanese manufacturing giants catching up in low-cost production, laying the groundwork for losses in the 1990s.
1990
Losses and Restructuring Failure
Unable to withstand the consumer electronics price war initiated by Japan's Matsushita and Sony, Philips recorded a net loss of 4.2 billion Dutch guilders in 1990, setting a European corporate loss record for that era. The board replaced the CEO, and the company was forced to spin off semiconductor plants and low-margin hardware businesses, shifting resources toward medical systems and lighting. This was Philips' first true divestment of non-core assets, laying the foundation for its later focus strategy.
2016
Spin-off and Slimming Down Turning Point
In 2016, Philips spun off its lighting business into an independently listed company, raising approximately 770 million euros on the Amsterdam Stock Exchange. This spin-off marked Philips officially abandoning the century-old mass appliance path ranging from lightbulbs to televisions, concentrating all resources on healthcare equipment and diagnostic systems. Post-spin-off, over 60% of the company's revenue came from health tech, transforming it into a medical enterprise.
2021
Quality Crisis Failure
In 2021, due to sound abatement foam in ventilators potentially releasing carcinogenic gases, Philips recalled over 5.5 million ventilators and sleep therapy devices globally. The recall triggered a wave of returns in North America, wiping out more than 10 billion euros of the company's market value within months, and then-CEO Frans van Houten resigned in 2022. Philips was forced to rebuild its supply chain and product safety systems while ceding North American ventilator market share to competitors.
Turning Points
- Established the NatLab laboratory in 1914, shifting from lighting into X-ray and medical equipment domains
- Co-created the CD standard with Sony in 1983, pushing Philips to the peak of consumer electronics
- Incurred a massive loss of 4.2 billion Dutch guilders in 1990, forcing the launch of asset divestitures and layoff reforms
- Spun off Philips Lighting in 2016, making a complete pivot to the medical technology track
- The 2021 ventilator recall incident compelled the company to reshape its quality management system
Failures & Pitfalls
- Suffered a net loss of 4.2 billion Dutch guilders in 1990 due to the Japanese price war, setting a European loss record
- The dot-com bubble burst in 2001, causing Philips' sales to plunge and its stock price to be cut in half
- Recalled 5.5 million ventilators in 2021, with North American market share eroded by ResMed and Chinese manufacturers
关键成功要素
- Chose carbon-filament lamps as the first product, seizing the market as Edison's patents expired
- Continuously invested in basic research, opening up the medical equipment market through X-ray tubes
- Partnered with Japanese enterprises in formulating CD and DVD standards to earn patent licensing fees
- Maintained focus through spin-offs and divestitures, shrinking from a home appliance giant into a medical technology company
- Strengthened shortfalls in diagnostics and monitoring through M&A, such as acquiring Volcano Corporation and other vascular imaging companies
Lessons
- If a technological beacon is not translated into mass-producible products, it will be breached faster by Asian manufacturing
- Diversified expansion masks profit tumors; continuous divestment of non-core assets is necessary to survive a century
- The safety and recalls of medical equipment dictate survival more than technological iteration; a single recall can destroy a decade of trust
- Brand licensing and OEM can boost short-term revenue, but they hollow out a century-old brand
Core Data
- Annual Revenue (FY2023)：18.17 billion euros (based on public disclosures, independent verification pending)
- Global Employees (End of 2023)：Approximately 69,000 (based on public disclosures, independent verification pending)
- Ventilator Recall Volume (Since 2021)：Over 5.5 million units (based on public disclosures, independent verification pending)
- Home Appliance Business Sale Price (2021)：3.7 billion euros, sold to Hillhouse Capital (based on public disclosures, independent verification pending)
- IPO Date：1912, Amsterdam Stock Exchange (based on public disclosures, independent verification pending)
Competitors / Peers
In the medical technology sector, Philips faces long-standing pressure from Siemens Healthineers and GE HealthCare in high-end imaging equipment such as CT and MRI, while experiencing cost-performance impacts from China's Mindray Medical in patient monitors, ultrasound, and basic medical equipment. In the respiratory health track, ResMed seized a significant share of home ventilators taking advantage of Philips' recall, and China's BMC Medical is also rapidly penetrating emerging markets. Following the divestment of its home appliance business, Philips' competitive landscape is no longer traditional appliance rivals like Bosch and Siemens, but a mixed battlefield composed of global medical equipment giants and Chinese dark horses.
Sources
- https://zh.wikipedia.org/wiki/%E9%A3%9E%E5%88%A9%E6%B5%A6
- https://hao.cnyes.com/post/226875
- https://user.guancha.cn/main/content?id=1509338
- https://www.eefocus.com/article/1632974.html
- http://storystudio.tw/article/gushi/%E8%8D%B7%E8%98%AD%E5%A5%87%E8%B9%9F%EF%BC%9A%E9%A3%9B%E5%88%A9%E6%B5%A6%E5%A6%82%E4%BD%95%E5%BE%9E%E7%87%88%E6%B3%A1%E5%B7%A5%E6%88%BF%E8%AE%8A%E8%BA%AB%E9%9B%BB%E5%AD%90%E5%B8%9D%E5%9C%8B%EF%BC%881
- https://www.ledinside.cn/news/20160215-37726.html